Biosimilars: An Overview

Sponsored by NAMCP and AAMCN.

This activity is an archive from the webinar held November 17, 2016
 

While not accredited, this activity is designed to be educational and we do want your input after the webcast. Please click the link for the electronic evaluation after participating.

These presentations require Adobe Flash Player.  You can download it here.
 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is sponsored by Sandoz, a Novartis Company

PLEASE CLICK HERE TO VIEW THE PRESENTATION IN FLASH

PLEASE CLICK HERE TO VIEW THE PRESENTATION IN HTML5

PLEASE CLICK HERE FOR EVALUATION

Description
Biologic agents have revolutionized the treatment of many diseases, including cancer, diabetes, hepatitis, inflammatory bowel disease, and rheumatoid arthritis. A biosimilar is a biologic drug that is developed to be highly similar to an existing biologic. This webinar is designed to provide you with information on biosimilar science, clinical development, and regulatory updates.

Upon Completion of this activity, participants will be able to:

  • Understand what biosimilars are

  • Recognize the complexity of development

  • Review regulatory developments

  • Identify methods of reaching physicians and patients
     

Faculty: Carlos Sattler, MD
Head, Clinical Development and Medical Affairs
Sandoz, Inc.

This activity is sponsored by Sandoz, a Novartis Company

NAMCP and/or this website do not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.